American Association for Cancer Research--96th Annual Meeting. Anticancer agents--part II.
Phillips
Tom
T
Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London W1T 4JE, UK. tom.phillips@thomson.com
Collins
Tracey
T
Davies
Jamie
J
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001419:Bacteria; D019496:Cancer Vaccines / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D020258:Neurotoxicity Syndromes / Q000503:physiopathology; D014780:Viruses
D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D004791:Enzyme Inhibitors